Foreign Affairs Committee, Health Subcommittee, Energy and Commerce Committee
Introduced
In Committee
On Floor
Passed Chamber
Enacted
Binational Health Strategies Act of 2021 This bill requires the President and the United States-Mexico Border Health Commission to take certain actions related to COVID-19. Specifically, the bill directs the President to seek to begin negotiations with Mexico to address infectious disease preparedness in the U.S.-Mexico border area with respect to COVID-19 and other infectious diseases. The bill further requires the United States-Mexico Border Health Commission to (1) report on the border area's response to COVID-19 in both the United States and Mexico, (2) submit a binational strategic plan with respect to COVID-19, and (3) submit a plan to prepare and respond to future infectious diseases within the border area.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
International Affairs
ArizonaCaliforniaCardiovascular and respiratory healthCongressional oversightDiplomacy, foreign officials, Americans abroadEmergency medical services and trauma careGovernment information and archivesHealth promotion and preventive careImmunology and vaccinationInfectious and parasitic diseasesLatin AmericaMedical tests and diagnostic methodsMexicoNew MexicoPresidents and presidential powers, Vice PresidentsTexas
Binational Health Strategies Act of 2021
USA117th CongressHR-1538| House
| Updated: 3/4/2021
Binational Health Strategies Act of 2021 This bill requires the President and the United States-Mexico Border Health Commission to take certain actions related to COVID-19. Specifically, the bill directs the President to seek to begin negotiations with Mexico to address infectious disease preparedness in the U.S.-Mexico border area with respect to COVID-19 and other infectious diseases. The bill further requires the United States-Mexico Border Health Commission to (1) report on the border area's response to COVID-19 in both the United States and Mexico, (2) submit a binational strategic plan with respect to COVID-19, and (3) submit a plan to prepare and respond to future infectious diseases within the border area.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Foreign Affairs Committee, Health Subcommittee, Energy and Commerce Committee
International Affairs
Introduced
In Committee
On Floor
Passed Chamber
Enacted
ArizonaCaliforniaCardiovascular and respiratory healthCongressional oversightDiplomacy, foreign officials, Americans abroadEmergency medical services and trauma careGovernment information and archivesHealth promotion and preventive careImmunology and vaccinationInfectious and parasitic diseasesLatin AmericaMedical tests and diagnostic methodsMexicoNew MexicoPresidents and presidential powers, Vice PresidentsTexas